Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

57.27 +0.80 (+1.43%)

Streaming Delayed Price Updated: 11:14 AM EDT, Jun 5, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	479,006
Open	56.09
Bid (Size)	57.25 (100)
Ask (Size)	57.30 (500)
Prev. Close	56.47
Today's Range	56.09 - 57.53
52wk Range	49.26 - 66.28
Shares Outstanding	183,352,255
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year ↗

May 30, 2026

Ultragenyx develops therapies for rare genetic diseases, with a portfolio spanning approved biologics and a pipeline of gene therapies.

Via The Motley Fool

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

May 21, 2026

What Happened? Shares of biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) jumped 7.3% in the afternoon session after the company announced positive resu...

Via StockStory

Performance

YTD	-3.7%	-3.7%
1 Month	+7.6%	+7.6%
3 Month	-5.4%	-5.4%
6 Month	+6.4%	+6.4%
1 Year	+2.1%	+2.1%

More News

1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky

May 21, 2026

Via StockStory

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Value Opportunity with Strong Fundamentals and Accelerating Growth ↗

May 19, 2026

Via Chartmill

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q1 Earnings Miss Masked by Raised 2026 Guidance ↗

May 04, 2026

Via Chartmill

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Emerges as a Compelling Value Stock ↗

April 17, 2026

Via Chartmill

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗

March 16, 2026

Via Chartmill

2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down

May 14, 2026

Via StockStory

BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 11, 2026

Via StockStory

BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook

May 05, 2026

Via StockStory

BioMarin (BMRN) Q1 2026 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

BioMarin Pharmaceutical (NASDAQ:BMRN) Misses Q1 CY2026 Revenue Estimates

May 04, 2026

Via StockStory

BioMarin (BMRN) Q4 2025 Earnings Transcript ↗

May 04, 2026

Via The Motley Fool

BioMarin Pharmaceutical (BMRN) Reports Earnings Tomorrow: What To Expect

May 02, 2026

Via StockStory

Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity

April 13, 2026

Via MarketMinute

2 Profitable Stocks with Promising Prospects and 1 Facing Challenges

April 08, 2026

Via StockStory

Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know

April 02, 2026

Via StockStory

Ultragenyx Vaults Toward Commercialization as FDA Accepts Landmark Gene Therapy BLA

April 02, 2026

Via MarketMinute

1 of Wall Street’s Favorite Stock with Promising Prospects and 2 We Find Risky

March 26, 2026

Via StockStory

Biotech Stock Up 372% Gets Sold as New Pick Rises 40% in 2026 ↗

March 20, 2026

Via The Motley Fool

This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position ↗

March 20, 2026

Via The Motley Fool

Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks

March 19, 2026

Via StockStory

This Investor Sold $104 Million of Nuvalent Stock Amid Cancer Drug Developer's Nearly 30% Rally ↗

March 16, 2026

Via The Motley Fool

This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally ↗

March 16, 2026

Via The Motley Fool

Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy? ↗

March 15, 2026

Via The Motley Fool

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?

Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.

What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?

BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?

The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market

What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?

The current price of BioMarin Pharmaceutical Inc. - Common Stock is 57.27

When was BioMarin Pharmaceutical Inc. - Common Stock last traded?

The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 06/05/26 11:14 AM ET

What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?

The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.50B

How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?

BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.